906649-94-3 Usage
Uses
Used in Pharmaceutical Industry:
2,6-dibromo-4-fluorotoluene is utilized as an intermediate in the production of various pharmaceuticals. Its unique structure and functional groups contribute to the synthesis of a range of medicinal compounds, enhancing their therapeutic properties and effectiveness in treating different health conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 2,6-dibromo-4-fluorotoluene serves as an essential intermediate for the development of agrochemicals. Its incorporation into these products helps improve their performance in crop protection, pest control, and other agricultural applications, ensuring increased crop yields and better resistance to various threats.
Used in Organic Synthesis:
2,6-dibromo-4-fluorotoluene is employed as a building block in the synthesis of various organic compounds and materials. Its bromine and fluorine substituents make it a versatile reagent for creating new molecules with specific properties, such as improved stability, reactivity, or selectivity, which can be applied in various industries.
Used in Chemical Research:
As a valuable reagent in chemical research, 2,6-dibromo-4-fluorotoluene is used to explore new reaction pathways, develop innovative synthetic methods, and study the properties of halogenated aromatic compounds. Its unique structure and reactivity provide researchers with valuable insights into the behavior of similar compounds and contribute to the advancement of chemical science.
Check Digit Verification of cas no
The CAS Registry Mumber 906649-94-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,6,6,4 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 906649-94:
(8*9)+(7*0)+(6*6)+(5*6)+(4*4)+(3*9)+(2*9)+(1*4)=203
203 % 10 = 3
So 906649-94-3 is a valid CAS Registry Number.
906649-94-3Relevant academic research and scientific papers
Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors
Giroux, Andre,Boulet, Louise,Brideau, Christine,Chau, Anh,Claveau, David,Cote, Bernard,Ethier, Diane,Frenette, Richard,Gagnon, Marc,Guay, Jocelyne,Guiral, Sebastien,Mancini, Joseph,Martins, Evelyn,Masse, Frederic,Methot, Nathalie,Riendeau, Denis,Rubin, Joel,Xu, Daigen,Yu, Hongping,Ducharme, Yves,Friesen, Richard W.
body text, p. 5837 - 5841 (2010/04/28)
Phenanthrene imidazoles 26 and 44 have been identified as novel potent, selective and orally active mPGES-1 inhibitors. These inhibitors are significantly more potent than the previously reported chlorophenanthrene imidazole 1 (MF63) with a human whole blood IC50 of 0.20 and 0.14 μM, respectively. It exhibited a significant analgesic effect in a guinea pig hyperalgesia model at oral doses as low as 14 mg/kg. Both active and selective mPGES-1 inhibitors (26 and 44) have a relatively distinct pharmacokinetic profile and are suitable for clinical development. Crown Copyright
